An observational study in Cancers, Atheroscleroses, Coronary and Atherosclerosis of Artery, sponsored by Sakakibara Heart Institute. Completed. Per ClinicalTrials.gov, last updated 2019-12-18.
Sponsored by Sakakibara Heart Institute · Observational
As previously reported (IJC Heart \& Vasculature 2017; 17: 11.), our epidemiological analysis showing high incidence of cancers in patients with atherosclerotic cardiovascular diseases as compared with those with non-atherosclerotic cardiovascular diseases may imply a clinical possibility of a role of atherosclerosis in cancer developments. In the present study, to address our hypothesis that cancer developments may come with a strength of atherosclerosis, we traced an incidence of cancers in a total of 8,856 patients with coronary artery diseases (CAD) for a median follow-up of 1,095 days (interquartile range, 719-1,469 days) using the Sakakibara Health Integrative Profile (SHIP) database.
In accordance with a presence or absence of poly-arterial diseases such as aortic and/or peripheral artery diseases as an indicator of a strength of atherosclerosis, an incidence of cancers and all-cause death in two cohorts of 8,140 patients with CAD-only and 716 with CAD with poly-arterial diseases were evaluated to track an incidence of cancers and ali-cause mortality during median follou-up periods of 3 to 4 years.
39 studies on the registry are indexed under Carcinogenesis; 10 are open to participants now.
This study's enrollment of 8,856 is above the median of 278 across 22 observational studies indexed under Carcinogenesis.
Browse Carcinogenesis studies →Sakakibara Heart Institute is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
same as eligibility criteria
Exclusion Criteria:
patients with diagnosed coronary artery diseases (CAD) without any other atherosclerotic cardiovascuar diseases at the entry of SHIP
Other: incidece of cancers
patients with diagnosed coronary artery diseases (CAD) with other atherosclerotic cardiovascuar diseases such as any of aortic and/or peripheral artery diseases at the entry of SHIP
Other: incidece of cancers
With a continuous surveillance system to track all subsequent incidents of cardiovascular diseases and/or non-cardiovascular diseases via direct contact in the outpatient department, hospital records, and a mailed questionnaire at least once a year, an incidence of cancers was identified
inicidence of cancers
number of all types of cancers during follow-up periods
Time frame: through study completion, an average of 3 years
all-cause mortality
number of all types of death during follow-up periods
Time frame: through study completion, an average of 3 years
No study locations are listed for this record.
Plan to share: No — After completed, the data will be shared with simlar study investigators over the world
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sakakibara Heart Institute